# Dexamethasone (Sterodex) Versus Loteprendol (Lotemax) Eye Drops Following Strabismus Surgery

> **NCT02825186** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Ophthalmology

## Interventions

- **DRUG:** Loteprendol etabonate 0.5%
- **DRUG:** Dexamethasone 0.1%

## Key facts

- **NCT ID:** NCT02825186
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825186, "Dexamethasone (Sterodex) Versus Loteprendol (Lotemax) Eye Drops Following Strabismus Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02825186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*